Nanomedicine News

RSS

Nanoparticle System Decorated with Nanobodies to Locate Cellular Source of Brain Damage

Traumatic brain injury is currently revealed by using a series of physiological and cognitive tests along with standard medical imaging, such as magnetic resonance imaging (MRI). The techniques are excellent for diagnosis of moderate to severe traumatic brain injury, but less effective for diagnosing mild injury and for predicting the extent of its impact.

From Arizona State University 17 Dec 2014

NetScientific Invests in PDS Biotechnology

NetScientific, the biomedical and healthcare technology group, today announced it has made an investment in PDS Biotechnology Corporation (‘PDS’).

16 Dec 2014

Cristal Therapeutics Completes New €6 Million Financing Round

Biopharmaceutical company Cristal Therapeutics has completed a new financing round of over €6 million which includes investments from new and existing investors and a national innovation fund. Venture capital investor Chemelot Ventures joins as a new shareholder and existing investors Thuja Capital, BioGeneration Ventures, Nedermaas, Utrecht University Holding and Beheer Innovatiefonds Provincie Limburg also contributed.

16 Dec 2014

Gold Nanoparticle Sensor System Can Accurately Profile Anti-Cancer Drugs

Traditional genomic, proteomic and other screening methods currently used to characterize drug mechanisms are time-consuming and require special equipment, but now researchers led by chemist Vincent Rotello at the University of Massachusetts Amherst offer a multi-channel sensor method using gold nanoparticles that can accurately profile various anti-cancer drugs and their mechanisms in minutes.

16 Dec 2014

NantWorks and Sorrento to Establish The Immunotherapy Antibody JV

Sorrento Therapeutics, Inc., an oncology company developing new treatments for cancer and associated pain, announced today that it has entered into a binding agreement with NantWorks founder, physician scientist, and biotechnology entrepreneur Dr. Patrick Soon-Shiong.

16 Dec 2014

Nanomaterial Coatings Improve Strength, Biocompatibility of Hip and Knee Replacements

Washington State University researchers are working to improve materials used in hip and knee replacements so that they last longer and allow patients to quickly get back on their feet after surgery.

15 Dec 2014

COBRA PzF Stent System with Polyzene-F Nano-Thin Coating Safe for Heart Disease Treatment

CeloNova BioSciences, Inc., today announced results from a First-in-Man (FIM) clinical trial presented by Luc Maillard, MD PhD, at the prestigious French Cardiology Meeting, GRCI, held in Paris, France. In his presentation entitled, “First-in-man expérience avec le stent Cobra-PzF, utilisant un nano-coating,” Dr. Maillard concluded that the COBRA PzF™ coronary stent system with advanced nano-thin coating of Polyzene™-F polymer can be a safe and effective interventional treatment for real-world and complex patients with heart disease.

15 Dec 2014

Fast Pulsed Magnetic Fields Help Focus Nano-Therapeutic Magnetic Particles to Deep Targets

Recent efforts between the University of Maryland (UMD) and Bethesda-based Weinberg Medical Physics LLC (WMP) have led to a new technique to magnetically deliver drug-carrying particles to hard-to-reach targets. The method has the potential to transform the way deep-tissue tumors and other diseases are treated.

12 Dec 2014

Bioreplication Offers Better 3D Resolution at the Nanoscale

Changing flesh to stone sounds like the work of a witch in a fairy tale.

From Sandia National Laboratories 12 Dec 2014

Nanoparticles Target Hard-to-Reach Cancers Without Causing Damaging Side Effects

Scientists at Brunel University London have found a way of targeting hard-to-reach cancers and degenerative diseases using nanoparticles, but without causing the damaging side effects the treatment normally brings.

12 Dec 2014